Analyse @carlzimmer's tweets
@carlzimmer
| 286,047 followers
Paxlovid rebounds, FDA looks kindly on baricitinib but rejects fluvoxomaine for Covid + more: here’s the latest update to the @nytimes Covid treatment tracker https://t.co/tQ2oCXOjs0